Issue 4/2019
Content (7 Articles)
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis
Kiyonori Kuwahara, Shigeo Ohba, Shunsuke Nakae, Natsuki Hattori, Eriel Sandika Pareira, Seiji Yamada, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma
Jiro Akimoto, Shinjiro Fukami, Tomohiro Suda, Megumi Ichikawa, Rei Haraoka, Michihiro Kohno, Yukiko Shishido-Hara, Toshitaka Nagao, Masahiko Kuroda
Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
Aruna Nambirajan, Prit Benny Malgulwar, Agrima Sharma, Meher Thej Boorgula, Ramesh Doddamani, Manmohan Singh, Vaishali Suri, Chitra Sarkar, Mehar Chand Sharma
A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations
Yoshiko Nakano, Kai Yamasaki, Hiroaki Sakamoto, Yasuhiro Matsusaka, Noritsugu Kunihiro, Hiroko Fukushima, Takeshi Inoue, Mai Honda-Kitahara, Junichi Hara, Akihiko Yoshida, Koichi Ichimura
Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature
Shoh Sasaki, Ran Tomomasa, Sumihito Nobusawa, Junko Hirato, Tomoko Uchiyama, Eishu Boku, Toshiteru Miyasaka, Takanori Hirose, Chiho Ohbayashi
Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a “spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant”
Maki Sakaguchi, Yoshiko Nakano, Mai Honda-Kitahara, Masashi Kinoshita, Shingo Tanaka, Masahiro Oishi, Kazuhiro Noguchi, Masaki Fukuda, Hideaki Maeba, Takuya Watanabe, Yutaka Hayashi, Hiroko Ikeda, Hiroshi Minato, Koichi Ichimura, Takayuki Nojima, Mitsutoshi Nakada